ALECTOR INC - NO SIGNIFICANT EFFECTS ON ALZHEIMER'S BIOMARKERS OR AMYLOID LEVELS FROM INVOKE-2 PHASE 2 TRIAL

Reuters · 11/25 21:05

Please log in to view news